HealthQuill Medical
UK-based DIOSynVax, a biotechnology company, has developed a single candidate vaccine neutralizing immune responses across the spectrum of very diverse H5 subtypes of influenza viruses.
Drugs Health Medical

UK’s DIOSynVax develops single candidate vaccine for bird flu virus

UK-based DIOSynVax, a biotechnology company, has developed a single candidate vaccine neutralizing immune responses across the spectrum of very diverse H5 subtypes of influenza.

Read More
British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic disorder.
Drugs Health Medical

AstraZeneca in $1.92 million deal with HK-listed CSPC Pharmaceutical

British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic.

Read More
Extreme warming in the Antarctic Peninsula has increased the vegetation cover in the region by more than tenfold over the last four decades, according to researchers from the universities of Exeter and Hertfordshire and the British Antarctic Survey.
Climate Health Medical

Vegetation cover in Antarctic Peninsula increases 10-fold in last four yrs: Study

Extreme warming in the Antarctic Peninsula has increased the vegetation cover in the region by more than tenfold over the last four decades,.

Read More
he Democratic Republic of the Congo has started mpox vaccination aiding efforts to halt the spread of the viral disease, according to the World Health Organization.
Drugs Health Medical

Congo begins mpox vaccination in eastern region, roll-outs in 11 provinces

he Democratic Republic of the Congo has started mpox vaccination aiding efforts to halt the spread of the viral disease, according to the.

Read More
Global corporations worldwide are now adapting to a "new normal," where WFH is becoming standard practice, either fully or partially. While seeking a "new normal," there is growing concern about mental health outcomes associated with WFH.  A study examining WFH experiences during lockdown found that most respondents reported more positive than negative experiences. 
Drugs Health Medical Opinion

Opinion: Work from home debate rages on as Mental Health Day nears

By Aparna S As we inch toward October 10, Mental Health Day, the ‘Workplace Mental Health’ theme for 2024 needs to be put.

Read More
According to the United Nations, one in ten people worldwide were aged 65 years and above in 2021. By 2050, this number is estimated to be one in six persons globally.
Drugs Health Medical

Geriatric falls a greater economic burden than firearms injuries

HQ Team October 4, 2024: Falls among the elderly population are a leading cause of injury and can lead to immense physical, emotional.

Read More
The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year to 16, government data showed.
Drugs Health Medical

California state confirms two cases of bird flu, US total stands at 16 now

The US state of California has confirmed two human cases of bird flu, bringing the total number of cases in the current year.

Read More
Climate Health Medical

‘Communities take primacy in any conversation around health’: Interview

In our search for websites and organizations engaged in community health, public policy and similar endeavors, we came across “The Third Eye’.  Named.

Read More
Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.
Drugs Health Medical

Harvard develops drug-free nasal spray to block viruses, bacteria

Harvard University researchers have developed a drug-free nasal spray that blocks, and neutralizes viruses and bacteria.

Read More
Eli Lilly and Company will build a $4.5 billion center for advanced manufacturing and drug development in Indiana to innovate new production methods.
Drugs Health Medical

Lilly to invest $4.5 billion to build Medicine Foundry in Indiana state, US

Eli Lilly and Company will build a $4.5 billion center for advanced manufacturing and drug development in Indiana to innovate new production methods.

Read More